Defining ETS transcription regulatory networks and their contribution to breast cancer progression

被引:45
作者
Turner, David P.
Findlay, Victoria J.
Moussa, Omar
Watson, Dennis K. [1 ]
机构
[1] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA
关键词
ETS; transcriptional regulation; breast cancer; microenvironment; proteome;
D O I
10.1002/jcb.21494
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ETS factors are members of one of the largest families of evolutionarily conserved transcription factors, regulating critical functions in normal cell homeostasis, that when perturbed contribute to tumor progression. The well docunnented alterations in ETS factor expression and function during breast cancer progression result in pleiotropic effects manifested by the downstream effect on their tat-get genes. Multiple ETS factors bind to the same regulatory sites present on target genes, suggesting redundant or competitive functions. Furthermore, additional events contribute to, or may be necessary for, target gene regulation. in order to advance our understanding of the ETS-dependent regulation of breast cancer progression and metastasis, this prospect article puts forward a model for examining the effects of simultaneous expression of multiple transcription factors on the transcriptome of non-metastatic and metastatic breast cancer. Compared to existing RNA profiles defined following expression of individual transcription factors, the anti- and prometastatic signatures obtained by examining specific ETS regulatory networks will significantly improve our ability to accurately predict tumor progression and advance our understanding of gene regulation in cancer. Coordination of multiple ETS gene functions also mediates interactions between tumor and stromal cells and thus contributes to the cancer phenotype. As such, these new insights I nay provide a novel view of the ETS gene family as well as a focal point for studying the complex biological control involved in tumor progression.
引用
收藏
页码:549 / 559
页数:11
相关论文
共 52 条
[1]  
Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018
[2]   HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer [J].
Benz, CC ;
OHagan, RC ;
Richter, B ;
Scott, GK ;
Chang, CH ;
Xiong, XH ;
Chew, K ;
Ljung, BM ;
Edgerton, S ;
Thor, A ;
Hassell, JA .
ONCOGENE, 1997, 15 (13) :1513-1525
[3]   Proteomics of breast cancer - Principles and potential clinical applications [J].
Bertucci, Francois ;
Birnbaum, Daniel ;
Goncalves, Anthony .
MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) :1772-1786
[4]   Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes [J].
Bissell, M. J. ;
Kenny, P. A. ;
Radisky, D. C. .
MOLECULAR APPROACHES TO CONTROLLING CANCER, 2005, 70 :343-356
[5]   PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells [J].
Boire, A ;
Covic, L ;
Agarwal, A ;
Jacques, S ;
Sherifl, S ;
Kuliopulos, A .
CELL, 2005, 120 (03) :303-313
[6]   HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1 [J].
Bosc, DG ;
Goueli, BS ;
Janknecht, R .
ONCOGENE, 2001, 20 (43) :6215-6224
[7]   Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics [J].
Brand, M ;
Ranish, JA ;
Kummer, NT ;
Hamilton, J ;
Igarashi, K ;
Francastel, C ;
Chi, TH ;
Crabtree, GR ;
Aebersold, R ;
Groudine, M .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (01) :73-80
[8]   Ets2 transcription factor in normal and neoplastic human breast tissue [J].
Buggy, Y ;
Maguire, TM ;
McDermott, E ;
Hill, ADK ;
O'Higgins, N ;
Duffy, MJ .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (04) :485-491
[9]   Overexpression of the Ets-1 transcription factor in human breast cancer [J].
Buggy, Y ;
Maguire, TM ;
McGreal, G ;
McDermott, E ;
Hill, ADK ;
O'Higgins, N ;
Duffy, MJ .
BRITISH JOURNAL OF CANCER, 2004, 91 (07) :1308-1315
[10]   P53 ALTERATIONS IN ALL STAGES OF BREAST-CANCER [J].
DAVIDOFF, AM ;
KERNS, BJM ;
PENCE, JC ;
MARKS, JR ;
IGLEHART, JD .
JOURNAL OF SURGICAL ONCOLOGY, 1991, 48 (04) :260-267